Blaze Medical Devices LLC develops technology to facilitate testing of blood damage and health of red blood cells (RBC), specifically hemolysis and mechanical fragility. The company's testing services and products offer profiling of RBC mechanical fragility for various applications. The company offers its technologies as Research-Use Systems, Clinical Systems, and Testing Services. The companyâs principal product lines include RBC Mechanical Fragilimeter⢠systems for testing the mechanical fragility (MF) of red blood cells, and RBC Hemolysis Tester systems which also include the Fragilimeter⢠capability. Applications of this technology include Pharmaceutical R&D, Medical Device R&D, Transfusion Research, and Diagnostic Resea
